EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSECRG00000014663
Gene Symbol: DPYD
3 Cross references
231 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSECRG00000011414
Gene Symbol: DDR2
2 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSECRG00000012720
Gene Symbol: DRD1
3 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSECRG00000015767
Gene Symbol: DRD2
3 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSECRG00000000838
Gene Symbol: DRD3
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSECRG00000000794
Gene Symbol: DRD4
3 Cross references
245 Possible Orthologues:

Duodenase-1-Like

Ensembl ID : ENSECRG00000018207
Gene Symbol: LOC114662713
2 Cross references
986 Possible Orthologues:

Duodenase-1-Like

Ensembl ID : ENSECRG00000014047
Gene Symbol: LOC114662648
2 Cross references
1125 Possible Orthologues:

Duodenase-1-Like

Ensembl ID : ENSECRG00000013998
Gene Symbol: LOC114662647
2 Cross references
1125 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSECRG00000019935
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSECRG00000016369
Gene Symbol: EGLN1
3 Cross references
240 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSECRG00000016585
Gene Symbol: EGLN3
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).